Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Br J Dermatol. 2010 Mar;162(3):472-7. doi: 10.1111/j.1365-2133.2009.09582.x. Epub 2009 Dec 2.
Filaggrin is a key protein involved in skin barrier function. Mutations in the gene encoding filaggrin (FLG) have been identified as the cause of ichthyosis vulgaris and have been shown to be major predisposing factors for atopic eczema (AE), initially in European populations. Subsequently, FLG mutations were identified in Japanese, Chinese, Taiwanese and Korean populations. It was demonstrated that FLG mutations are closely associated with AE in the Japanese population. Notably, the same FLG mutations identified in the European population were rarely found in Asians. These results exemplify differences in filaggrin population genetics between Europe and Asia. For mutation screening, background information needs to be obtained on prevalent FLG mutations for each geographical population. It is therefore important to establish the global population genetics maps for FLG mutations. Mutations at any site within FLG, even mutations in C-terminal imperfect filaggrin repeats, cause significant reductions in amounts of profilaggrin/filaggrin peptide in patient epidermis as the C-terminal region is essential for proper processing of profilaggrin into filaggrin. Thus, no genotype-phenotype correlation has been observed in patients with FLG mutations. A restoration of the barrier function seems a feasible and promising strategy for treatment and prevention in individuals with filaggrin deficiency.
丝聚合蛋白是参与皮肤屏障功能的关键蛋白。编码丝聚合蛋白(FLG)的基因突变已被确定为寻常型鱼鳞病的病因,并已被证明是特应性皮炎(AE)的主要易感因素,最初在欧洲人群中发现。随后,在日本、中国、中国台湾和韩国人群中也发现了 FLG 突变。研究表明,FLG 突变与日本人群中的 AE 密切相关。值得注意的是,在欧洲人群中发现的相同 FLG 突变在亚洲人中很少见。这些结果说明了欧洲和亚洲人群中丝聚合蛋白群体遗传学的差异。为了进行突变筛查,需要了解每个地理人群中常见的 FLG 突变的背景信息。因此,建立 FLG 突变的全球人群遗传学图谱非常重要。FLG 内任何位置的突变,甚至 C 末端不完整丝聚合蛋白重复的突变,都会导致患者表皮中前丝聚合蛋白/丝聚合蛋白肽的含量显著减少,因为 C 末端区域对于前丝聚合蛋白正确加工成丝聚合蛋白至关重要。因此,在具有 FLG 突变的患者中没有观察到基因型-表型相关性。恢复屏障功能似乎是治疗和预防丝聚合蛋白缺乏症个体的一种可行且有前途的策略。